Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

  1. Pérez de Llano, L.A.
  2. Cosío, B.G.
  3. Domingo, C.
  4. Urrutia, I.
  5. Bobolea, I.
  6. Valero, A.
  7. Entrenas Costa, L.M.
  8. Quirce, S.
  9. Barranco, P.
  10. Marina Malanda, N.
  11. Andrés, L.P.
  12. Alvarez-Gutiérrez, F.J.
Journal:
Journal of Allergy and Clinical Immunology: In Practice

ISSN: 2213-2198

Year of publication: 2019

Volume: 7

Issue: 7

Pages: 2277-2283.e2

Type: Article

DOI: 10.1016/J.JAIP.2019.01.017 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus